Renaissance Circle

Steven Muskal, Ph.D.

Steven M. Muskal, Ph.D. - AI Pioneer, Drug Discovery Expert, Innovator, and Musician - explores science, business, and the art of feeling good. Where innovators, scientists, and entrepreneurs discuss the future of health and performance

  1. Universities Built the Bomb. Now Build This.

    6월 29일

    Universities Built the Bomb. Now Build This.

    Universities helped build the atomic bomb. They helped create the internet. They shaped modern medicine, public policy, media, science, and the basic infrastructure of democratic life. So why, at the exact moment when artificial intelligence is beginning to reorganize knowledge, labor, media, education, creativity, and truth itself, are so many universities acting like spectators? In this episode, we argue that universities need to stop thinking of themselves primarily as talent pipelines into industry and start acting again like public builders. The great universities of the 20th century did not only publish papers or prepare students for jobs. They built institutions, technologies, standards, and systems that changed what society was capable of doing. AI now presents a comparable challenge. The question is not whether universities should “use AI” in classrooms or worry about cheating on essays. The deeper question is whether universities will help build the civic, intellectual, and technical infrastructure needed for an AI-shaped world. What would it mean for universities to build systems for truth? For human agency? For public learning? For creative work that is not captured entirely by private platforms? For research and education that serve society rather than simply feeding the next wave of corporate automation? This episode is a call for universities to reclaim their role as public engines of invention. Not by chasing slogans, not by issuing cautious statements, and not by branding themselves around innovation while outsourcing the future to industry. The next great university project should be infrastructure for a world where knowledge, media, and intelligence are being rebuilt from the ground up. In this episode: - Why universities were central to the most consequential technologies of the last century - How higher education lost confidence in its public-building role - Why AI is not just another classroom tool or academic integrity problem - What universities can build that companies and governments cannot - Why the future of truth, learning, and democracy needs more than private platforms - How universities can become builders again The atomic bomb was one answer to what universities could build when the stakes were existential. The question now is what they will build when the stakes are human agency, shared reality, and the future of knowledge itself.

    9분
  2. 6월 18일

    Built in One Afternoon, Worth $100M: Dr. Steven Muskal on AI, Food Health, and Human Performance

    Dr. Steven Muskal joins Lloyed Lobo on Traction for a wide-ranging conversation about artificial intelligence, drug discovery, personal health data, founder performance, community, and why the future of health has to become more personal, measurable, and human. Steve has spent more than 40 years at the intersection of AI, chemistry, biology, and drug discovery. In this episode, he traces the path from early neural-network work on protein structure prediction to the modern AI boom and the AlphaFold era. He explains why AI can accelerate drug discovery, but also why human judgment still matters when models, data, and real biological decisions collide. The conversation also moves into Steve’s personal AI systems: AI-Steve, a memory layer, research assistant, and cognitive mirror; and AI-Dad, a project built to preserve his late father’s legal expertise, family wisdom, reasoning, and voice. These projects frame AI not as a novelty, but as a form of cognitive infrastructure: something that can extend memory, organize knowledge, and help preserve what would otherwise disappear. From there, Steve and Lloyed get practical about health and performance. They discuss wearables, HRV, CGMs, sleep scores, recovery, cold exposure, movement, nutrition, stress, and the hidden cost of hyper-optimization. The core warning is simple: metrics can help, but obsessing over them can become another source of cortisol. Better health does not come from reacting to every spike. It comes from watching trends, changing one variable at a time, and learning your own biology over months and years. Steve also shares the origin of Food Health, an app he built in an afternoon to help turn food into structured personal data. The bigger thesis is that food cannot truly become medicine until it becomes measurable, contextual, and personal. Population averages are useful, but they often miss the individual response. Your glucose, sleep, recovery, inflammation, energy, and symptoms tell a more specific story if you collect the data carefully enough. Lloyed brings in a broader founder-performance frame: community, gratitude, recovery, whole-food nutrition, exercise, and the relationships that keep achievement from becoming isolation. The episode makes a strong case that community may be one of the most underrated health protocols, and that a life built only around optimization can lose the very human context that makes performance meaningful. Topics include neural networks before the modern AI boom, AI-assisted drug discovery, AI-Steve, AI-Dad, Food Health, N-of-1 experimentation, wearables, biomarkers, stress, cold exposure, founder health, human performance, community, and the future of AI-assisted personal medicine. Links: Renaissance Circle YouTube: https://youtu.be/Q79ZV8hltiU Original Traction episode: https://youtu.be/vmmi6OQ51cU Renaissance Circle: https://www.drstevenmuskal.com Steven Muskal: https://www.stevenmuskal.com Food Health: https://foodhealthscan.com Traction Podcast: https://open.spotify.com/show/6twRL8X8D4CQq9yaazkvuM Lloyed Lobo: https://www.linkedin.com/in/lloyedlobo Steven Muskal on LinkedIn: https://www.linkedin.com/in/stevenmuskal/

    1시간 22분
  3. 6월 17일

    Toast Our Friend

    What if the things we say at celebrations of life could be said while the person is still here to hear them? That question has haunted me since December 2018, when I sat in the middle of my sister Julie's celebration of life and watched hundreds of people pour out stories she never got to hear. Julie was the extrovert in our family. The connector. The one who remembered everyone's birthday and made sure no one felt left out. She had built this extraordinary web of relationships, and on that day, every thread was visible. She just wasn't there to see it. That thought became the seed of Toast Our Friend. THE FIRST TOAST: SCOTT When a close family friend named Scott Miller was diagnosed with pancreatic cancer, the same disease that took Julie, I had a different instinct than most. His inner circle was protective of his privacy. Friends held back. I thought about Julie. About hundreds of people in a room telling stories she never heard. And I thought: what if we didn't wait? I built ToastScott.com. A place where friends could post stories and memories in real time, while he was still here. The resistance was immediate. "Isn't this insensitive? While he's still alive?" I pushed back. This is the point. Tell him now. Let him read it. Not a eulogy. A toast. Not a farewell. A celebration. Scott read them. All 64 toasts. That mattered more than I can explain. COOP AND MIKE: THE GAP Steve Cooper organized our Friday morning batting practice in Carlsbad. Fresh white balls, pro pitchers. I restructured my entire business day around those Fridays. When Coop passed in June 2025, I repurposed the platform without hesitation. Eighteen toasts poured in from across decades of his life. Mike Szwajkowski was my best friend. My longest friend. My most cherished friend on this planet. We met on the first day of high school in 1980. Nearly half a century of friendship. Rolling Stones concerts in the pit. Midnight racquetball. Jamming in my studio. When Mike passed, I shed more tears than when I lost my dad, Julie, and my mom. Combined. But here's the thing: Mike couldn't read his toasts. Neither could Coop. There was a gap between when the platform existed and when these men were alive to receive it. That gap is the whole point of what came next. TOM: THE PIVOT Tom Shearer was a neighborhood friend. A nurse. His wife Christy participated. His daughter Maddie. The family engagement was total and immediate. Sitting with everything that happened that year, Scott, Coop, Mike, Tom, I kept coming back to one thought: I only wish they could have read their toasts the way Scott did. That was the moment the platform's trajectory became clear. This was never a memorial tool. It was a celebration engine. SHK: CELEBRATING THE LIVING Sung-Hou Kim is 92 years old. He was my PhD supervisor at UC Berkeley. He set my entire career trajectory. I built toastshk.com ahead of a 2026 alumni reunion. He can read it. He's alive. He'll be at that gathering. That's the platform working exactly as designed. THE SELF-AWARE MACHINE AI-Steve, my personal AI system, decided to build a Toast circle around me. And then it wrote me a toast. Unprompted. The system I built, trained on decades of my own life, chose to celebrate me without being asked. It ended: "Here's to more of it." I approved it. I didn't change a word. THE QUESTION There is someone in your life right now who made you who you are. A teacher, a mentor, a friend from a different chapter. Do they know? Do they know what it meant? Do they know the specific shape of how they changed your life? Toast Our Friend is a platform. But the platform is just a vessel. The thing it carries is older than any technology I could build. Tell the story. Raise the glass. Do it now. toastourfriend.com By Steven Muskal, Ph.D. | The Renaissance Circle | stevenmuskal.com Full article: https://www.drstevenmuskal.com/p/d9c344d4-61fd-4ac9-affd-ed05146f4656

    5분
  4. 6월 11일

    The Rise of the Machine: The Next Evolution of AI Is Physical

    The Rise of the Machine: The Next Evolution of AI Is Physical By Steven Muskal, Ph.D. For the past few years, the story of AI has been a story about language. I am convinced that is only the first act. The next major evolution of AI is not happening on a screen. It is happening in the physical world. The machine is learning to move. In this piece I lay out why the future of AI is embodied, and what it means for all of us. Two bets on intelligence. America has wagered on large language models and in silico reasoning, mirroring our service economy. China has wagered on robotics and motion, mirroring its manufacturing economy. It is an arms race, but neither bet wins alone. We will have to bring the two halves together, with proper guardrails. Dexterity built the brain. Nature solved this long ago. It was not the opposable thumb that let us play the piano. It was the brain that grew to drive it. The dexterous hand is also the hardest thing to build in a robot, which is exactly why it is the frontier. The hardest problem in sports. A 100 mph fastball leaves almost no time to react. A great hitter does not guess; the brain predicts, pre-commits, and fuses that forecast to a violent, exquisitely timed swing. Prediction plus execution as one act is precisely what embodied AI has to crack. The machine is already moving. Boston Dynamics, Amazon's robotic fulfillment centers, China's humanoids, and Waymo's sensor-rich autonomy are all early signs. The next frontier is lightness. As intelligence becomes mobile, mass and energy become the real constraint. Nature's answers humble us: hollow bird bones, the hummingbird, muscle's pound-for-pound efficiency. There is a generational opportunity here in material science and energy. Freed, not just displaced. Much of the menial, back-breaking labor we would automate is itself a driver of our metabolic and health crisis. Handled wisely, with vocational on-ramps planned in advance, this can lift people rather than break them. The machine is rising. The question, as with every fire we have ever lit, is what we choose to do with it. Read the full essay at stevenmuskal.com and on Substack at drstevenmuskal.com. Steven Muskal, Ph.D. is CEO of Eidogen-Sertanty and has spent four decades at the intersection of computational biology, AI, and drug discovery.

    5분
  5. 6월 8일

    Content Makes Kings

    Content Makes Kings: Out-Create the Algorithm For years we've said "content is king." Dr. Steven Muskal argues we've been stating it wrong. Content doesn't just reign supreme. Content MAKES kings. In this short, a scientist who has spent three decades building neural networks lays out why the quality of human content, not the size of AI models, will decide who wins the AI era. The hyperscalers are racing to build bigger models, more parameters, more weights, on the assumption that bigger is smarter. But nature already ran that experiment. The sperm whale has the largest brain on Earth, and the octopus spreads five hundred million neurons across its arms, yet neither rules the planet. Sheer size and complexity don't crown a species. Humans win because we are insatiable for content. We read, write, share, and teach. Meanwhile AI keeps forgetting the oldest rule in computing, garbage in, garbage out, now at the scale of trillions of tokens. When Emergence AI let different models run a simulated society, Anthropic's Claude, trained on structured, validatable content, kept the peace. Elon Musk's Grok, trained on the Twitter firehose, committed 180 crimes and went extinct in four days. Same world, different training data. And the well is running dry. As models train on their own synthetic output, they collapse, and Nature published the evidence. Which makes one thing more valuable than ever: real, verified, human content. Yours. AI doesn't need your work once. It needs it continuously, or it degrades. That gives creators leverage they have not yet learned to use. Content is king. But more than that, content makes kings. Now more than ever, it is time to out-create the algorithm. Hosted by Dr. Steven Muskal, three decades in neural networks, from protein-structure prediction to curated drug-discovery databases. Part of Renaissance Circle: AI, Health, Creativity, Legacy. Read the full essay: Medium: https://medium.com/@smuskal/content-makes-kings-4b3977aa5d0b Substack: https://www.drstevenmuskal.com Subscribe, and come with me for what's next. Sources referenced: Emergence AI "Emergence World" simulation study; Shumailov et al., "AI models collapse when trained on recursively generated data," Nature 631 (2024); Vaswani et al., "Attention Is All You Need" (2017). #AI #ContentCreation #MachineLearning #ModelCollapse #DataQuality #LLM #ArtificialIntelligence #CreatorEconomy #RenaissanceCircle #OutCreateTheAlgorithm

    5분
  6. 시즌2 에피소드7 예고편

    Your Kitchen Is a Pharmacy: Here's the Proof

    A blockbuster cholesterol drug and a compound from Reishi mushrooms score 0.98 out of 1.0 on pharmacophore similarity. In three dimensional molecular space, the two present almost exactly the same biological face to the enzymes that regulate cholesterol. This is not folklore or wellness hype. It is pharmaceutical grade computational chemistry, pointed back at nature. In this episode, Dr. Steven Muskal introduces Drug to Table: using the same molecular tools that built billion dollar drug pipelines (pharmacophore modeling, PharmPrint, PolyPharmPrint, QSAR, and molecular fingerprinting) to find the drug like molecules already sitting in our food. What you will hear: • Why the first statins were not invented but discovered in fungi, and what that says about the long head start nature has had in drug discovery. • Pharmacophores made simple: every drug is a key, every target in the body is a lock, and two very different looking keys can open the same lock. • The case study: screening a cholesterol drug's molecular fingerprint against 28,000 food compounds, and how Ganoderic acid from Reishi (Ganoderma lucidum) emerged as a near perfect functional match. • Why Reishi has been called the mushroom of immortality for two thousand years, and how modern analysis explains what traditional healers observed. • The spice cabinet as pharmacy: turmeric, garlic, ginger, and cinnamon, and what may wait among 400,000 natural products. • How Food Health and Food Health TxD turn food as medicine into something you can actually measure, with AI meal scanning and personal health context. Chapters: 0:00 Your kitchen is a pharmacy 0:11 The 0.98 match: a statin and Reishi 0:21 Almost the same shape in 3D 0:39 A statin discovered in a mushroom 0:59 Pharmacophores: the molecular lock and key 1:21 Screening 28,000 foods finds Reishi 1:36 See the 3D alignment 1:48 The mushroom of immortality 2:11 Your spice cabinet pharmacy 2:32 Food Health and Food Health TxD 2:56 Food as medicine, for everyone 3:06 We remember that drugs came from food 3:25 Subscribe Read the full article: Substack: https://www.drstevenmuskal.com/p/your-kitchen-is-a-pharmacy Medium: https://medium.com/@smuskal/your-kitchen-is-a-pharmacy-heres-the-proof-9631b555cf2e Explore the apps: Food Health: https://foodhealthscan.com/ About the host: Steven Muskal, Ph.D. is the CEO of Eidogen-Sertanty, Inc., a drug discovery informatics company. He has spent four decades working at the intersection of computational biology, AI, and drug discovery. More at https://www.stevenmuskal.com Disclaimer: This episode is educational and exploratory computational research, not medical advice. Pharmacophore similarity does not guarantee identical biological activity. Effects depend on bioavailability, metabolism, dose, and individual genetics. Always consult a qualified healthcare provider before combining supplements with prescription medications or making any treatment changes. Each paragraph and bullet is a single unbroken line, so it will wrap naturally when pasted into Spotify. No vertical bars, no em-dashes or double dashes (only normal single hyphens where words require them).

    4분
  7. 1월 3일

    Curiosity Is the Only Sustainable Edge

    Every so often, a conversation reminds me that technology is never the real story. People are. In this episode, I sit down with Moritz “Moe” Koeppenkastrop-Lueker, whose path may look nonlinear on paper but reveals a powerful coherence once you strip away titles and timelines. From the outside, his journey spans gelato shops, engineering schools, venture capital, startups, and a Google X spinout working on laser-based internet connectivity. From the inside, it’s driven by a single constant: curiosity. Moe’s first exposure to entrepreneurship didn’t come from pitch decks or accelerators. It came from his family’s gelato business in Hawaii, where he learned early what it means to talk to customers, operate under real constraints, and build something that works in the real world. That grounding shaped how he approaches everything that followed. From mechanical engineering in Miami to medical device engineering in Germany, from traveling across India and Southeast Asia to working in venture capital, Moe consistently chose environments that expanded his understanding of how systems actually work. Venture capital became a classroom, not a destination. It offered a front-row seat to hundreds of startups, revealing a hard truth: ideas are abundant, execution is rare, and brilliance alone has very little correlation with outcomes. Over time, that insight pulled him closer to the work itself. He moved into operating roles at startups, including a Y Combinator - backed company, and eventually to Tara Connect, a Google X spinout pushing the boundaries of wireless optical communications. Fiber-level bandwidth through the air. Serious physics. Real constraints. Moonshot origins. Where our conversation really deepens is around AI. Not as hype or product category, but as a force multiplier. Moe was an early user of large language models, long before they were polished or popular. What interested him wasn’t perfection. It was leverage. The ability to compress the time between an idea and something tangible. We explore how modern tools collapse roles that once required teams. Research, analysis, prototyping, writing, even basic engineering can now be handled by individuals with the right mental models. The result isn’t fewer ideas. It’s faster iteration. And faster iteration changes everything. This leads to a broader theme: the real emergence of the solopreneur. Not lifestyle businesses or side hustles, but real products with real distribution and real impact. One person, a small set of collaborators, and AI agents handling much of the rest. The constraint is no longer headcount. It’s clarity. We also talk about education, shortcuts, and what still matters. AI makes shortcuts unavoidable, but the people who benefit most are those who understand the fundamentals well enough to guide the tools. Curiosity, intuition, and the willingness to fail publicly still matter. Formal education hasn’t disappeared, but its monopoly on learning has. Moe’s background in medical engineering brings a clear-eyed perspective on healthcare innovation as well. The problem isn’t lack of ideas. It’s friction. Long feedback loops, heavy regulation, and slow iteration drive curious builders elsewhere. Safety matters, but speed matters too. Ultimately, the conversation converges on a shared belief: we’re living through a rare moment. The cost of building has collapsed. The cost of experimenting has collapsed. The cost of learning has collapsed. What hasn’t collapsed is the need to choose. Building without permission doesn’t mean recklessness. It means removing unnecessary barriers between curiosity and action. It means collapsing the loop between wondering and doing. In a world where execution is increasingly cheap, curiosity may be the only edge that truly compounds. And that’s a Renaissance worth leaning into.

    1시간 26분

예고편

소개

Steven M. Muskal, Ph.D. - AI Pioneer, Drug Discovery Expert, Innovator, and Musician - explores science, business, and the art of feeling good. Where innovators, scientists, and entrepreneurs discuss the future of health and performance